Recorded during the AHSP Midyear Meeting, this webcast discusses translating outcomes from T2DM cardiovascular trials into clinical practice to implement individualized management strategies for patients with T2DM at high risk of or with a history of CVD.
This webcast examines the most recent evidence-based guidelines to optimize individualized tyrosine kinase inhibitor (TKI) selection for CML patients based on disease phase, treatment history, genetic mutation profile, and comorbidities.
This webcast discusses current guideline recommendations for ovarian cancer and strategies to improve the incorporation of recommendations into clinical pathways for ovarian cancer treatment.
40 min
About HMP CME (Audio)
From the publisher's feed
HMP CME serves as a powerful, year-round medical education resource featuring both in person and online offerings.